While we did not find reports connecting SIGLEC15 expression with breast cancer recurrence, it was previously shown to play a crucial role in a suppression of anti-tumor T-cell immune responses (Hiruma, Hirai & Tsuda, 2011; Wang et al., 2019). Here, SIGLEC15 is linked to neoplasm.